tiprankstipranks
Valion Bio (VBIO)
NASDAQ:VBIO
US Market
VBIO
Valion Bio
RESEARCH TOOLSreports
Want to see VBIO full AI Analyst Report?

Valion Bio (VBIO) Income Statement

167 Followers

Valion Bio Income Statement

Last quarter (Q2 2026), Valion Bio's total revenue was $778.77K, an increase of Infinity% from the same quarter last year. In Q2, Valion Bio's net income was $-633.38K. See Valion Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Mar 20Mar 19Mar 18Mar 17
Total Revenue
$ 0.00$ 0.00$ 0.00$ 102.42K$ 163.36K
Gross Profit
$ 0.00$ 0.00$ 0.00$ 24.48K$ 55.10K
Operating Expenses
$ 2.34M$ 3.69M$ 5.94M$ 4.42M$ 3.53M
Depreciation and Amortization
$ 1.46M$ -672.65K$ 12.27K$ 87.75K$ -1.75M
EBITDA
$ -880.85K$ -4.37M$ -4.43M$ -4.31M$ -5.22M
Operating Income
$ -2.34M$ -3.69M$ -4.57M$ -4.40M$ -3.47M
Other Income/Expenses
$ 1.46M$ 60.48K$ 117.33K$ 87.75K$ -1.75M
Pretax Income
$ -880.85K$ -3.63M$ -4.45M$ -4.31M$ -5.22M
Net Income
$ -880.85K$ -4.37M$ -20.14M$ -4.31M$ -5.22M
Per Share Metrics
Basic EPS
$ -0.02$ -0.09$ -0.61$ -0.19$ -0.38
Diluted EPS
$ -0.02$ -0.09$ -0.61$ -0.19$ -0.38
Weighted Average Shares Outstanding
 50.84M 50.84M 33.00M 23.12M 13.59M
Weighted Average Shares Outstanding (Diluted)
 50.84M 50.84M 33.00M 23.12M 13.59M
Currency in USD

Valion Bio Earnings and Revenue History